Gelatin-siloxane hybrid scaffolds with vascular endothelial growth factor induces brain tissue regeneration

Curr Neurovasc Res. 2008 May;5(2):112-7. doi: 10.2174/156720208784310204.

Abstract

In the brain after infarction or trauma, the tissue becomes pannecrotic and forms a cavity. In such situation, a scaffold is necessary to produce new tissue. In this study, we implanted a new porous gelatin-siloxane hybrid derived from gelatin and 3-(glycidoxypropyl) trimethoxysilane (gelatin-GPTMS) scaffolds into a brain defect, and investigated whether it makes a new brain tissue. In addition, vascular endothelial growth factor (VEGF) was added on gelatin-GPTMS scaffolds and its effect on tissue regeneration was examined. At 30 days after the implantation, the marginal territory of the scaffolds became occupied by newly formed tissue. Immunohistochemical analysis revealed that the new tissue was constituted by endothelial, astroglial and microglial cells, some of which were labeled for bromodeoxyuridine (BrdU). Addition of VEGF promoted numbers of these cells. Thus, combination of gelatin-GPTMS scaffolds and VEGF is preferable for brain regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants
  • Animals
  • Brain Injuries / pathology
  • Brain Injuries / physiopathology
  • Brain Injuries / surgery*
  • Bromodeoxyuridine / metabolism
  • Cell Proliferation / drug effects
  • Disease Models, Animal
  • Gelatin* / therapeutic use
  • Male
  • Nerve Regeneration / drug effects*
  • Nerve Regeneration / physiology
  • Nerve Tissue Proteins / metabolism
  • Rats
  • Rats, Wistar
  • Siloxanes* / therapeutic use
  • Tissue Scaffolds*
  • Vascular Endothelial Growth Factor A / therapeutic use*

Substances

  • Nerve Tissue Proteins
  • Siloxanes
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Gelatin
  • Bromodeoxyuridine